Category:Kevin HENRY

Kevin HENRY

Executive Summary

Kevin HENRY is an inventor who has filed 2 patents. Their primary areas of innovation include Antineoplastic agents (2 patents), PEPTIDES (peptides in foodstuffs (2 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (1 patents), and they have worked with companies such as National Research Council of Canada (2 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations), (1 collaborations).

Patent Filing Activity

File:Kevin HENRY Monthly Patent Applications.png

Technology Areas

File:Kevin HENRY Top Technology Areas.png

List of Technology Areas

• A61P35/00 (Antineoplastic agents): 2 patents
• C07K16/2863 (PEPTIDES (peptides in foodstuffs): 2 patents
• A61K35/17 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K39/4611 ({Cellular immunotherapy}): 1 patents
• A61K39/4631 ({Cellular immunotherapy}): 1 patents
• A61K39/464404 ({Cellular immunotherapy}): 1 patents
• A61K39/464411 ({Cellular immunotherapy}): 1 patents
• C07K16/2809 (PEPTIDES (peptides in foodstuffs): 1 patents
• A61K2239/13 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K2239/29 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/6803 ({Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates}): 1 patents
• A61K49/00 (Preparations for testing in vivo): 1 patents
• C12N5/16 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• A61K2039/505 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents

Companies

File:Kevin HENRY Top Companies.png

List of Companies

• National Research Council of Canada: 2 patents

Collaborators

• Martin ROSSOTTI (1 collaborations)
• Mehdi ARBABI-GHAHROUDI (1 collaborations)
• Scott MCCOMB (1 collaborations)
• Risini WEERATNA (1 collaborations)
• Jamshid TANHA (1 collaborations)
• Maria Luz JARAMILLO (1 collaborations)
• Colin Roger MACKENZIE (1 collaborations)
• Anne MARCIL (1 collaborations)